お知らせ

The 77th Annual Meeting of The Japanese Pharmacological Society
Osaka, Japan
March 8 - 10, 2004

We are glad to inform you that The Seventy-Seventh Annual Meeting of The Japanese Pharmacological Society will be held in Osaka, from Monday, March 8 to Wednesday, March 10, 2004. As the hosts of this meeting, we extend a warm invitation to you to attend this conference at the Osaka International Congress Center. For further information, the members of the Society should refer to Folia Pharmacologica Japonica and non-members should contact Professor Miki by E-mail.

We encourage you to join and enjoy this exciting meeting.

Correspondence:
Professor Naomasa Miki
Department of Pharmacology
Osaka University Medical School
Suita 565-0871, Japan
Phone: +81-6-6879-3521
Fax: +81-6-6879-3529
E-mail: nmiki@pharma1.med.osaka-u.ac.jp
URL: http://pharma1.med.osaka-u.ac.jp/yakuri77/

Scientific Program
The scientific program for the Meeting consists of five Plenary Lectures, two Invited Lectures, three Educational Lectures, forty-eight Symposia, about six hundred oral presentations, and about a thousand poster presentations, covering all pharmacological fields. Prize Lectures by young investigators awarded by The Japanese Pharmacological Society are also planned. Topics for the lectures and symposia are as follows:

Plenary Lectures (alphabetical order)

  1. Bloom, F.E. （Scripps Research Institute） "Neuroinformations: a new path to drug development"
  2. Corvol, P. （College de France） "Gene hunting in cardiovascular disease"
  3. Jentsch, T.J. （Universitat Hamburg） "Pathophysiology of chloride transport: lessons from mouse models and human disease"
  4. Kishimoto, T. (Osaka University) "IL-6: from laboratory to clinical"
  5. Lefkowitz, R.J. （Duke University） "β-Arrestins: master regulators of seven membrane spanning receptors"

Invited Lectures

  1. Endou, H. (Kyorin University) "Transporter and development of new drugs"
  2. Satoh, M. (Kyoto University) "Pain and its molecular mechanisms of regulation"

Educational Lectures

  1. Kobayashi, Y. (Osaka University) "Structural biology: analysis of protein-protein interaction"
  2. Katamine, S. (Nagasaki University) "Advance of prion disease research: perspective for treatment and prevention"
  3. Okabe, S. (Kyoto Pharmaceutical University) "Progress in gastrology: these 40 years"　

Symposia

  1. Update on agents for rheumatoid arthritis
  2. Frontiers in drug transporter research
  3. Up to date: studies on serotonin transporter
  4. Neuronal insulin signalings and their functional roles
  5. Glutamate receptors and brain functions
  6. Transcriptional regulation of neuronal genes and its effect on neural functions
  7. Prostaglandins and brain diseases
  8. Neuronal morphologies and functions
  9. Signal transduction pathways controlling neural circuit formation and neuronal morphogenesis
  10. Induction of neural differentiation and its application for the regeneration
  11. Topics on the mechanism of ER stress involvement in the regulation of brain cell death
  12. Update of the therapeutic drugs for Alzheimer's disease
  13. Recent progress of molecular pathophysiology and regeneration of neurodegenerative disorders
  14. Wound healing mechanisms: from basal understandings to regenerative medicine and drug developments
  15. Neuronal genesis and death: aspects from cell cycle regulation
  16. Development of alternative animal experiments in pharmacology
  17. Development of novel tools and methods for pharmacological study
  18. Creation and development of informatics for pharmacological science: application of genome network to pharmacology
  19. Role and regulation of non-phagocyte NADPH oxidase: a potential target for drug discovery
  20. The latest frontiers in the treatment of allergic inflammation: basic analysis and clinical research
  21. Histamine-related discoveries
  22. Further pharmacological objectives in renin-angiotensin system
  23. Malfunction of vascular control in life-style related diseases
  24. Pharmacotherapy of osteoporosis
  25. Drug-induced QT prolongation: strategy and evaluation of nonclinical and clinical studies
  26. Drug-induced fatal arrhythmias
  27. Molecular mechanism of cardiac remodeling and heart failure: new target molecule for therapy
  28. Pathophysiology in cardiovascular-related organs and new approaches to develop their therapeutic medicines
  29. Molecular pharmacology of emotion: basis for improvement of QOL
  30. New perspectives for studies of emotional experience and expression: from animals to humans
  31. Genomic approach to the development of new drugs for the treatment of psychiatric disorders
  32. Molecular mechanism of drug dependence: new horizon of drug development
  33. New perspectives in the studies on endocannabinoids and cannabis
  34. Recent advances in research on physiological roles of nicotinic acetylcholine receptors
  35. Nuclear receptors on diseases: nuclear receptors as targets for drug development
  36. Resolution and application of mechanotransduction mechanisms as a target for new drugs
  37. New expansion of sensation pharmacology
  38. Pathophysiological roles of lipoxygenases and leukotrienes
  39. Channel/transporter and disease
  40. Molecular mechanisms and drug development in aquaporin water channel diseases
  41. Protein folding and ER function for drug development
  42. Regulation of protein nitration and its function
  43. Physiology and pathophysiology of protease-activated receptors (PARs)
  44. Protein tyrosine phosphatases: biology and pathology
  45. Recent progress in signal transduction towards the discovery of therapeutic agents
  46. Novel functions of calmodulin-dependent signal transduction and drug development
  47. Functional proteins involved in regulation of intracellular Ca2+ for drug development
  48. Heterogeneity of G protein-coupled receptor generated by posttranslational mechanisms and its clinical meanings
Publication
Proceedings of the Meeting will be published in the Journal of Pharmacological Sciences as Supplement 1 of Vol. 94, 2004

このページの先頭へ